Human Vaccinia-related Kinase 1 (VRK1) Activates the ATF2 Transcriptional Activity by Novel Phosphorylation on Thr-73 and Ser-62 and Cooperates with JNK
Open Access
- 1 June 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (26) , 27458-27465
- https://doi.org/10.1074/jbc.m401009200
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Expression of the VRK (vaccinia‐related kinase) gene family of p53 regulators in murine hematopoietic developmentFEBS Letters, 2003
- Transcriptional regulation by the phosphorylation-dependent factor CREBNature Reviews Molecular Cell Biology, 2001
- AP-1 in cell proliferation and survivalOncogene, 2001
- The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor proteinOncogene, 2000
- ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylationNature, 2000
- The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1AOncogene, 1999
- Activation of the Rat Cyclin A Promoter by ATF2 and Jun Family Members and Its Suppression by ATF4Experimental Cell Research, 1998
- Modulation of AP‐1/ATF transcription factor activity by the adenovirus‐e1a oncogene productsBioEssays, 1995
- Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleusCurrent Biology, 1995
- Phosphorylation of cAMP response element-binding protein, CRE-BP1, by cAMP-dependent protein kinase and protein kinase CBiochemical and Biophysical Research Communications, 1991